Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome
May 12, 2022 06:50 ET
|
Bright Minds Biosciences
-- Review of Phase I ready BMB-101 and upcoming milestones -- -- Webcast to be held on May 19, 2022, 4:00pm ET -- VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Bright Minds...
Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results
August 09, 2016 16:01 ET
|
Zogenix, Inc.
EMERYVILLE, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
Zogenix Announces Agreement to Refinance Debt, Further Increasing Company’s Expected 2017 Cash Balance
June 21, 2016 08:00 ET
|
Zogenix, Inc.
- Interest-only repayment provision results in $10 million increase to Zogenix’s expected cash balance at the end of 2017 - EMERYVILLE, Calif., June 21, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc....
Zogenix Announces Initiation of Multi-National Phase 3 Clinical Trial for ZX008 in Dravet Syndrome
June 07, 2016 08:00 ET
|
Zogenix, Inc.
EMERYVILLE, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders,...
Zogenix Announces New Efficacy and Safety Data on ZX008 for Treatment of Seizures in Dravet Syndrome
May 05, 2016 08:00 ET
|
Zogenix, Inc.
Patient and Caregiver Sleep Quality and Quality of Life Data Reported for First Time New Clinical Data Presented at 14th International Child Neurology Congress on the Use of Low-Dose Fenfluramine...
Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome
January 19, 2016 08:00 ET
|
Zogenix, Inc.
EMERYVILLE, Calif., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today...
Nuvilex, Inc.'s Marijuana Research Into Cannabidiol Could Lead to Many Successes
October 03, 2013 10:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Nuvilex, Inc. (OTCQB: NVLX) formed its subsidiary, Medical Marijuana Sciences, Inc., to study the medical applications of marijuana, and more...
CeCe Cares Pediatric Epilepsy Foundation Honors the 1st Anniversary of CeCe Cunningham's Passing
March 09, 2011 09:24 ET
|
CeCe Cares - Pediatric Epilepsy Foundation
CHICAGO, March 9, 2011 (GLOBE NEWSWIRE) -- CeCe Cares Pediatric Epilepsy Foundation, a nonprofit organization created to provide comfort to children diagnosed with Pediatric Epilepsy, help families...